Patient dropouts before completion of optimal dose, multiple allergen immunotherapy
- 31 March 1999
- journal article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 82 (3) , 281-286
- https://doi.org/10.1016/s1081-1206(10)62609-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Guidelines to minimize the risk from systemic reactions caused by immunotherapy with allergenic extractsJournal of Allergy and Clinical Immunology, 1994
- Monoclonal antibody–standardized cat extract immunotherapy: Risk-benefit effects from a double-blind placebo studyJournal of Allergy and Clinical Immunology, 1994
- Survey of fatalities from skin testing and immunotherapy 1985–1989Journal of Allergy and Clinical Immunology, 1993
- A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: Clinical efficacy and side effectsJournal of Allergy and Clinical Immunology, 1993
- Determinants of patient compliance with allergen immunotherapyJournal of Allergy and Clinical Immunology, 1993
- Immunotherapy With AllergensJAMA, 1992
- Systemic reactions from allergen immunotherapyJournal of Allergy and Clinical Immunology, 1992
- Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injectionsJournal of Allergy and Clinical Immunology, 1990
- The safety of allergenic immunotherapyJournal of Allergy and Clinical Immunology, 1990
- Fatalities from immunotherapy (IT) and skin testing (ST)Journal of Allergy and Clinical Immunology, 1987